These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30340948)

  • 1. Coronary Artery Bypass Grafting Versus Percutaneous Transcatheter Coronary Interventions: Analysis of Outcomes in Myocardial Revascularization.
    Cormican D; Jayaraman AL; Sheu R; Peterson C; Narasimhan S; Shaefi S; Núñez-Gil IJ; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2019 Sep; 33(9):2569-2588. PubMed ID: 30340948
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-long clinical outcome after the first myocardial revascularization procedures: 40-year follow-up after coronary artery bypass grafting and percutaneous coronary intervention in Rotterdam.
    Milojevic M; Thuijs DJFM; Head SJ; Domingues CT; Bekker MWA; Zijlstra F; Daemen J; de Jaegere PPT; Kappetein AP; van Domburg RT; Bogers AJJC
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):852-859. PubMed ID: 30753554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease.
    Spinthakis N; Farag M; Gorog DA; Prasad A; Mahmood H; Gue Y; Wellsted D; Nabhan A; Srinivasan M
    Int J Cardiol; 2017 Dec; 249():101-106. PubMed ID: 28958756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
    Grubb KJ; Kirtane AJ
    Circulation; 2022 Jan; 145(3):155-157. PubMed ID: 34882433
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.
    Park DW; Ahn JM; Yun SC; Yoon YH; Kang DY; Lee PH; Lee SW; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Park SJ
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2813-2822. PubMed ID: 30261236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing hybrid coronary revascularization: challenges, controversies and opportunities.
    Kayatta MO; Halkos ME
    Expert Rev Cardiovasc Ther; 2016 Jul; 14(7):821-30. PubMed ID: 27042753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Inflammatory Responses Between Robotically Enhanced Coronary Artery Bypass Grafting and Conventional Coronary Artery Bypass Grafting: Implications for Hybrid Revascularization.
    Leyvi G; Vivek K; Sehgal S; Warrick A; Moncada KA; Shilian N; Leff JD; Michler RE; DeRose JJ
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):251-258. PubMed ID: 28807577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).
    Biancari F; Gudbjartsson T; Heikkinen J; Anttila V; Mäkikallio T; Jeppsson A; Thimour-Bergström L; Mignosa C; Rubino AS; Kuttila K; Gunn J; Wistbacka JO; Teittinen K; Korpilahti K; Onorati F; Faggian G; Vinco G; Vassanelli C; Ribichini F; Juvonen T; Axelsson TA; Sigurdsson AF; Karjalainen PP; Mennander A; Kajander O; Eskola M; Ilveskoski E; D'Oria V; De Feo M; Kiviniemi T; Airaksinen KE
    Am J Cardiol; 2014 Jul; 114(2):198-205. PubMed ID: 24878127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.
    Kassimis G; Patel N; Banning AP
    Curr Pharm Des; 2014; 20(28):4589-96. PubMed ID: 24568733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
    Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
    J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?
    Koskinas KC; Windecker S
    Herz; 2016 May; 41(3):224-32. PubMed ID: 27048841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S
    Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease.
    Mulukutla SR; Gleason TG; Sharbaugh M; Sultan I; Marroquin OC; Thoma F; Smith C; Toma C; Lee JS; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):474-480. PubMed ID: 31056197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
    Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry.
    Lowenstern A; Wu J; Bradley SM; Fanaroff AC; Tcheng JE; Wang TY
    Am Heart J; 2019 Sep; 215():167-177. PubMed ID: 31349108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.